News

Varsavsky chooses Madrid for the preclinical studies in Europe of his startup Gameto

Read article

Related Articles

News

Gameto Raises $23M to Redefine Reproductive Longevity with Reprogrammed Ovarian Cells

News

The 20(+1) under 40: Your guide to the next generation of biotech leaders

News

Gameto licenses Wyss Institute’s technology for growing human ovaries from Harvard University